Author/Authors :
Bouhabel, A Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria , Takoucht, F Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria , Bousbia, W Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria , Hamada, B Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria , Lemaiaci, N Constantine Military Hospital - Departments of Nephrology, Urology, and Pathology, Algeria
Abstract :
The initial treatment of bladder cancer is transurethral resection (TUR), but this cancer recurs at an important rate, and has 14% chance of progression after TUR alone. Intravesical chemotherapy with Bacillus Calmette-Guerin (BCG) is effective against recurrence and progression of bladder cancer. However, this therapeutic expose to many local and systemic side-effects. We report a case of 63-year-old man who presented bladder tuberculosis after a BCG therapy, which required 6 months of antitubercular therapy.
Keywords :
Bladder cancer , BCG therapy , Tuberculosis , Antitubercular
